And so if you think about it, the depressing thing is that

The first of these is informed consent.

Now, researchers need to make every effort to ensure that an intervention that has been shown to be beneficial during a clinical trial is accessible to the participants of the trial once the trial has been completed.

Of a drug that Dr. Bell created in '81

You have to go to the clinic to do it.

So, the problem is that the clinical trial was done, and we were a part of it, and in the fundamental clinical trial the pivotal clinical trial we call the Phase Three, we refused to use a placebo.

That's about it.

Every year or so,

Now, this is subject to a lot of debate and controversy.

I do not stand here today to suggest in any way that conducting HlV clinical trials in developing countries is bad.

We can do high frequency monitoring to get objective data.

So we know it can work.

They had to give it also in the U.S. to get approval, so I think there were three U.S. patients in upstate New York who were part of the trial.

There was, it turns out, a second clinical trial.

Think about iPods compared to stereos.

What does the system look like?

And it's not just because of regulation it's because of the amount of money needed under the current evidence based medicine and the size of trials and so on to make it happen.

Three years ago, she entered the Novocure lung cancer trial.

So the first one I'm going to talk about are implanted medical devices.

The second wish is, at the present time, the clinical trials of transcranial magnetic stimulators that's what TMS means, device to treat migraine headaches appears to be quite successful.

But when you start to read the article by Cliff, who himself is a cancer survivor, who was saved by a clinical trial where his parents drove him from New York City to upstate New York to get an experimental therapy for at the time Hodgkin's disease, which saved his life, he makes remarkable points here.

It is approved under an FDAlDE at the University of Virginia in Charlottesville using focused ultrasound to ablate a point in his thalamus.

The final point I would like for you to consider tonight is what happens to participants in the clinical trial once the research has been completed.

A medical device I sell for a living.

Also, research within the continent is a lot easier to conduct due to widespread poverty, endemic diseases and inadequate health care systems.

And the good news was that the FDA was running a clinical trial to figure out whether interfere on and medication that was originally approved for hairy cell leukemia was going to be successful for treating hepatitis C.

(Laughter)

The cells genetically know what to do, and they start beating together.

It's actually scary. It's beautiful.

This is especially important in developing countries, where a lot of participants consent to research because they believe it is the only way in which they can receive medical care or other benefits.

Examination?

I think it is absolutely wrong for research to begin in the first place without a clear plan for what would happen to the participants once the trial has ended.

So, we went back, and we've been working harder yet.

There are 170 clinical trials investigating the role of stem cells in heart disease.

The material is actually being coated with the cells.

Or should they be given an alternative standard of care, such as the best current treatment available in the country in which the research is being conducted?

What has changed our society has been wireless devices.

And their features match the pain and the gain.

However, the best current treatment available anywhere in the world is often very difficult to provide in developing countries.

As we speak, there are 117 or so clinical trials researching the use of stem cells for liver diseases.

At this point, he was told by his doctors that he had about 3 months to live.

In fact, she need not have hurried.

As part of a clinical trial for sleep disorders.

What I had for medical purposes...

You all know about embryonic stem cells.